Institutional Ownership Catalyst Pharmaceuticals, Inc. (CPRX)
This table provides information about the institutional ownership of Catalyst Pharmaceuticals, Inc. (CPRX). We have compiled data on the 388 institutions that hold shares in the stock, with a total of 99.3 Million shares, which have been reported (via 13F filing form) to have a value of $2.42 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
18,694,918
shares
|
$455 Million
0.01% of portfolio
|
Q2 2024
Added 5.43%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
8,495,580
shares
|
$207 Million
0.0% of portfolio
|
Q1 2025
Added 0.76%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
5,530,437
shares
|
$135 Million
0.01% of portfolio
|
Q1 2025
Reduced 4.59%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
May 15, 2025 Q1 2025 |
3,422,149
shares
|
$83.2 Million
2.1% of portfolio
|
Q1 2025
Added 9.23%
|
|
|
Goldman Sachs Group Inc
New York, NY |
May 16, 2025 Q1 2025 |
3,135,473
shares
|
$76.3 Million
0.01% of portfolio
|
Q1 2025
Added 11.89%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 14, 2025 Q1 2025 |
2,956,316
shares
|
$71.9 Million
0.12% of portfolio
|
Q1 2025
Added 9.25%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
2,765,556
shares
|
$67.3 Million
0.01% of portfolio
|
Q1 2025
Added 3.75%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
2,394,555
shares
|
$58.2 Million
0.0% of portfolio
|
Q1 2025
Added 14.68%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 13, 2025 Q1 2025 |
2,187,422
shares
|
$53.2 Million
0.01% of portfolio
|
Q1 2025
Reduced 27.4%
|
|
|
Terry Smith
Fundsmith LLP | London, X0
|
May 15, 2025 Q1 2025 |
2,151,274
shares
|
$52.3 Million
0.24% of portfolio
|
Q1 2025
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
1,811,475
shares
|
$44.1 Million
0.0% of portfolio
|
Q1 2025
Added 15.47%
|
|
|
Royce & Associates LP
|
May 06, 2025 Q1 2025 |
1,598,360
shares
|
$38.9 Million
0.44% of portfolio
|
Q1 2025
Reduced 14.27%
|
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
1,486,198
shares
|
$36.1 Million
0.01% of portfolio
|
Q1 2025
Reduced 1.16%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
1,326,771
shares
|
$32.3 Million
0.01% of portfolio
|
Q1 2025
Added 6.4%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,304,391
shares
|
$31.7 Million
0.01% of portfolio
|
Q4 2024
Added 14.51%
|
|
|
Boston Partners
Boston, MA |
May 12, 2025 Q1 2025 |
1,275,325
shares
|
$31 Million
0.04% of portfolio
|
Q1 2025
Reduced 1.28%
|
|
|
Invesco Ltd.
Atlanta, GA |
May 12, 2025 Q1 2025 |
1,199,627
shares
|
$29.2 Million
0.01% of portfolio
|
Q1 2025
Added 41.66%
|
|
|
Kennedy Capital Management, Inc.
St Louis, MO |
May 13, 2025 Q1 2025 |
1,061,323
shares
|
$25.8 Million
0.64% of portfolio
|
Q1 2025
Added 4.29%
|
|
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
May 14, 2025 Q1 2025 |
1,035,029
shares
|
$25.2 Million
0.02% of portfolio
|
Q1 2025
Added 48.25%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
977,623
shares
|
$23.8 Million
0.0% of portfolio
|
Q1 2025
Reduced 19.57%
|
|
|
Macquarie Group LTD
Australia, C3 |
May 15, 2025 Q1 2025 |
934,925
shares
|
$22.7 Million
0.03% of portfolio
|
Q1 2025
Added 36.95%
|
|
|
Pacer Advisors, Inc.
Malvern, PA |
May 06, 2025 Q1 2025 |
854,367
shares
|
$20.8 Million
0.06% of portfolio
|
Q1 2025
Reduced 71.09%
|
|
|
Skandinaviska Enskilda Banken Ab (Publ)
Stockholm, V7 |
May 07, 2025 Q1 2025 |
786,900
shares
|
$19.1 Million
0.1% of portfolio
|
Q1 2025
Added 7.51%
|
|
|
Nuveen, LLC
Charlotte, NC |
May 12, 2025 Q1 2025 |
768,012
shares
|
$18.7 Million
0.01% of portfolio
|
Q1 2025
New holding
|
|
|
Abrdn PLC
|
May 13, 2025 Q1 2025 |
765,294
shares
|
$18.6 Million
0.04% of portfolio
|
Q1 2025
Added 57.9%
|